BioSpace News Archive

The First World Longevity Forum and Life Science Conference (WLF&LSC), organized by Hezhou Municipal People’s Government, opened on Friday in Hezhou city, south China’s Guangxi Zhuang Autonomous Region.

According to Coherent Market Insights, global surgical drapes and gowns market was valued at US$ 2,410.4 million in 2017 and is projected to exhibit a CAGR of 4.9% over the forecast period (2018–2026).

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ra Medical Systems, Inc. of the August 6, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Heron Therapeutics, Inc. or the of the August 5, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that its senior management team led by Stephan Jackman, the Company’s CEO, and Ken Cragun, the Company’s CFO, will be participating in the annual Alzheimer’s Association International Conference® being held in Los Angeles, CA, from July 12 through July 18, 2019 at the L.A. Convention Center

Sensorion announces that it has received the Investigational New Drug clearance from the US Food and Drug Administration to proceed with SENS-401, based on preclinical data and clinical development plan.

New treatment can help Canadians living with hemophilia A better manage their bleeding episodes

The demand for desmopressin analogs is increasing from healthcare providers and patients because of the high efficacy of its different formulations.

Hanger, Inc., a leading provider of orthotic and prosthetic patient care services and solutions, announced it will report its financial results for the second quarter and six month period ended June 30, 2019 after the market closes on Wednesday, August 7, 2019.

First Non-Invasive Combined Occipital and Trigeminal Nerve Stimulation Device Charting New Course in Self-Administered Treatment of Migraine